HCPLive Network

Hormones, Vaginal Flora Impact Cervicovaginal Lavage

TUESDAY, April 1, 2014 (HealthDay News) -- Hormonal contraception use and vaginal flora all impact the properties of cervicovaginal lavage, according to a study published online March 24 in the American Journal of Obstetrics & Gynecology.

Catherine A. Chappell, MD, from the Magee-Womens Hospital at the University of Pittsburgh Medical Center, and colleagues examined the impact of contraception, menopause, and vaginal flora on the physical and biochemical properties of the cervicovaginal fluid. Participants included 165 healthy asymptomatic women, including 29 postmenopausal women; 26 women in the proliferative and 27 in the follicular phase; 28 women using the levonogestrel intrauterine device (LNG-IUD); 28 using depomedroxyprogesterone acetate (DMPA); and 27 using combined oral contraceptives. They measured the osmolality, viscosity, density, and pH of cervicovaginal lavage samples.

The researchers found that cervicovaginal lavage was less viscous and had higher pH in postmenopausal women and those with abnormal vaginal flora compared with premenopausal women and those with normal flora, respectively. Cervicovaginal lavage was more viscous for women using hormonal contraceptives versus premenopausal women not using contraceptives, but the presence of bacterial vaginosis mitigated this increase in viscosity. Cervicovaginal lavage had less total protein for women using DMPA versus LNG-IUD, but similar protein content compared with postmenopausal women.

"Contraceptive hormone users had more viscous CVL than women not using contraceptives," the authors write. "However, the presence of bacterial vaginosis impacted both the pH and viscosity (regardless of hormonal contraceptive use), demonstrating that vaginal flora has a greater impact on the physical properties of cervicovaginal fluid than reproductive hormones."

Abstract
Full Text (subscription or payment may be required)

Copyright © 2014 HealthDay. All rights reserved.

Further Reading
Metronidazole 1.3% has been approved by the FDA for treatment of bacterial vaginosis.
If women using hormonal contraceptives experience experience increases in fasting glucose and insulin levels it won't be significant enough to cause concern.
For women with diabetes, family planning is both a personal decision and a medical necessity, as unintended pregnancy can threaten a diabetic woman’s health.
Women with migraine with aura who use combined hormonal contraceptives have an increased risk of major thrombotic events; and migraine with aura is a strong contributor to major cardiovascular disease risk in women, according to two studies released in advance of their presentation at the annual meeting of the American Academy of Neurology, which will be held from March 16 to 23 in San Diego.
Researchers engineered an intravaginal device that will act as not only a contraceptive but also protect against HIV and herpes, according to a write up in PLOS ONE.
For women with vaginal prolapse after hysterectomy and levator ani avulsion, Prolift Total is associated with a lower anatomical failure rate than unilateral vaginal sacrospinous colpopexy with native tissue vaginal repair (sacrospinous fixation), according to a study published online March 11 in Ultrasound in Obstetrics & Gynecology.
Reflecting public feedback and concerns of some religious organizations, a Notice of Proposed Rulemaking has been issued for public comment regarding contraceptive coverage with no cost sharing under the health law.
More Reading